Bilcare Ltd
BSE:526853
Bilcare Ltd
Cash & Cash Equivalents
Bilcare Ltd
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bilcare Ltd
BSE:526853
|
Cash & Cash Equivalents
₹291.9m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-12%
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
Cash & Cash Equivalents
₹1.7B
|
CAGR 3-Years
58%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Dishman Carbogen Amcis Ltd
NSE:DCAL
|
Cash & Cash Equivalents
₹4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Syngene International Ltd
NSE:SYNGENE
|
Cash & Cash Equivalents
₹857m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Tarsons Products Ltd
NSE:TARSONS
|
Cash & Cash Equivalents
₹599.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
Innova Captab Ltd
NSE:INNOVACAP
|
Cash & Cash Equivalents
₹35.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bilcare Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
291.9m
INR
Based on the financial report for Dec 31, 2023, Bilcare Ltd's Cash & Cash Equivalents amounts to 291.9m INR.
What is Bilcare Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-12%
Over the last year, the Cash & Cash Equivalents growth was -38%. The average annual Cash & Cash Equivalents growth rates for Bilcare Ltd have been -15% over the past three years , -21% over the past five years , and -12% over the past ten years .